Rathinakumar Nivethia K, Nishanthi Anandabaskar, Manickam Shanthi
Department of Pharmacology, Sri Manakula Vinayagar Medical College and Hospital, Puducherry, India.
Perspect Clin Res. 2024 Jan-Mar;15(1):10-17. doi: 10.4103/picr.picr_64_23. Epub 2023 Oct 27.
To assess the perception and practices on COVID-19 vaccination and to determine the predictors of booster dose acceptability among health-care workers (HCWs) in South India.
We conducted an anonymous cross-sectional survey on the perception and practices on COVID-19 vaccination and booster dose acceptability among the HCWs in South India. We prepared an online self-administered validated questionnaire, and the Google form link to it was circulated from March 28, 2022 to April 27, 2022, in the social media groups of the HCWs. We used binary logistic regression to identify the predictors of booster dose acceptability among HCWs.
Overall, we obtained 572 valid responses, of which the majority were from paramedical workers compared to doctors. Most of the respondents were unmarried females aged <30 years. Around 31.6% had been previously diagnosed with COVID-19. About 97.9%, 88.8%, and 12.6% of the participants have taken the first, second, and booster doses of the COVID-19 vaccine, respectively. Among the respondents, 19.7% refused to take the booster dose. The main reason for booster dose refusal is the belief that two doses of the COVID-19 vaccine are sufficient to confer disease protection. Believing vaccination to be one of the most effective measures in COVID-19 prevention and being doctors by profession were the chief predictors of booster dose acceptance among HCWs.
While the uptake of the primary COVID-19 vaccination series was commendable among Indian HCWs, booster dose was taken only by a minority of them.
评估印度南部医护人员对新冠疫苗接种的认知和实践情况,并确定加强针可接受性的预测因素。
我们对印度南部医护人员关于新冠疫苗接种的认知、实践情况以及加强针可接受性进行了一项匿名横断面调查。我们编制了一份经验证的在线自填问卷,并于2022年3月28日至2022年4月27日在医护人员的社交媒体群组中分发其谷歌表单链接。我们使用二元逻辑回归来确定医护人员中加强针可接受性的预测因素。
总体而言,我们获得了572份有效回复,其中与医生相比,大多数来自辅助医务人员。大多数受访者是年龄小于30岁的未婚女性。约31.6%的人此前被诊断感染过新冠。分别约有97.9%、88.8%和12.6%的参与者接种了第一剂、第二剂和加强针新冠疫苗。在受访者中,19.7%的人拒绝接种加强针。拒绝接种加强针的主要原因是认为两剂新冠疫苗足以提供疾病防护。认为接种疫苗是预防新冠最有效措施之一以及职业为医生是医护人员中接受加强针的主要预测因素。
虽然印度医护人员对新冠疫苗基础接种系列的接受情况值得称赞,但只有少数人接种了加强针。